It should trade at a higher multiple if they can grow like that for sure.
Including adding back R&D in FY18, they make about 15% EBITDA margin, so if they get to $24m revenue organically in FY20, that would be about $3.6m EBITDA at 10.0x = $36m EV, so about 9.0 cents/share?
I actually think they can achieve better multiples and better financial results if they acquire.
JCurve Solutions (JCS) - Oracle, page-5
Add JCS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.267M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 153250 | 2.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.3¢ | 127573 | 2 |
View Market Depth
| Last trade - 16.12pm 10/09/2024 (20 minute delay) ? |
| JCS (ASX) Chart |
Day chart unavailable